A formal process inviting stakeholder and public comments on a draft recommendation before it is finalised.
HTA & Reimbursement
Terms for how health technology assessment bodies appraise new technologies and reach funding decisions.
- Topic: HTA & Reimbursement
- 43 terms
- Editor reviewed
A subsequent assessment of a previously reviewed technology, undertaken to incorporate new evidence or reconsider a decision given changed circumstances.
A reference case is a documented set of preferred methodological choices that an institution asks analysts to follow so economic evaluations are transparent, consistent and comparable for a defined decision context.
The formal determination by a payer regarding whether, and under what conditions, a technology will be financially covered for a population.
An ethical intuition describing the strong societal impulse to devote resources to rescuing identifiable individuals in immediate danger, even against cost-effectiveness logic.
The initial assessment stage in which the specific boundaries, including technology, population, comparators, and outcomes, are formally defined.
An assessment process focused on a single specific technology, typically a newly launched drug, unlike a multiple technology assessment.
The Scottish Medicines Consortium, advising Scotland's NHS boards on the clinical and cost-effectiveness of newly licensed medicines for local formulary decisions.